05-12-2020 09:00 via medpagetoday.com

Transplant Boosts OS in Older, High-Risk MDS Patients

(MedPage Today) -- Older, higher-risk myelodysplastic syndromes (MDS) patients who underwent allogeneic hematopoietic stem-cell transplantation had superior long-term survival compared to those who received best supportive care or hypomethylating...
Read more »